Physician collaborators speak out about LymphDetect at the 2026 AHNS meeting to a standing-room-only crowd Watch the Highlights

Company Overview Article from GenomeWeb: Droplet Biosciences Validates Lymph Fluid for Detecting Head and Neck Cancer Residual Disease

Dec 16, 2025

NEW YORK – Liquid biopsy firm Droplet Biosciences has validated its approach for using postoperative lymph fluid as a sample type for HPV-independent head and neck cancer detection.

Read the full article on GenomeWeb:

https://www.genomeweb.com/cancer/droplet-biosciences-validates-lymph-fluid-detecting-head-and-neck-cancer-recurrence